EMA
guidance
· 2022-04-22
Facilitating global access to diabetes treatments for non-EU patients
Summary
EMA outlines efforts to improve access to diabetes treatments for patients outside the European Union, aiming to facilitate global access and equitable availabi…
Upgrade for the full analysis, importance score, and drug timeline.